Board Members

Board

  • Frank Béraud*,
    Chief Executive Officer of Montréal InVivo
  • Cédric Bisson,
    Teralys Capital
  • Fabrice Brunet,
    CHUM and CHU Sainte-Justine
  • Claude Chevalier,
    Bio-k Plus International Inc.
  • Martha Cargo,
    McGill University
  • Frédéric Fasano,
    Servier Canada
  • Neil Fraser,
    Medtronic Canada
  • Diane Gosselin,
    CQDM
  • Chirfi Guindo,
    Merck Canada Inc.
  • Pavel Hamet,
    Medpharmgene
  • Marie-Josée Hébert*,
    Université de Montréal
  • Didier Leconte,
    Fonds de Solidarité FTQ
  • Paul Lepage,
    TELUS Health
  • Bruce Mazer,
    Research Institute of the McGill University Health Centre (RI-MUHC)
  • Jacques Milette,
    MEDTEQ
  • Ian Parfrement,
    Roche Diagnostics
  • Jean-Maurice Plourde,
    Honorary Member, Montréal InVivo
  • Vincent Poitout,
    Centre hospitalier de l'Université de Montréal [CHUM]
  • Rémi Quirion,
    Fonds de recherche du Québec – Santé (FRQS)

Chairman

  • Paul J. Lirette*,
    GlaxoSmithKline Pharma Canada (GSK)

Secretary-treasurer of the board

  • Pierre Falardeau*,
    Verlyx Pharma

Vice-chairman of the board

  • Jacques Gagné*,
    Honorary Member, Montréal InVivo
  • Martin LeBlanc*,
    Caprion Proteomics

« The strength of Montréal InVivo's Board of Directors is its ability to provide a single round table, bringing together all actors from the cluster, around a common goal: innovation and prosperity in its local industry »

Paul Lirette, Chairman of the Board of Directors

X

Subscribe to industry news

Which mailing list do you want to subscribe?

Flash InVivo
Info InVivo
Mailing list

What is your preferred language ?

French
English